Solange Peters

41PUBLICATIONS
94CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|May 30, 2026
Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

|Jan 20, 2026
Actionable driver gene alterations in early-stage non-small cell lung cancer: a review.

Ilaria Attili, Pasquale Pisapia, Gianluca Spitaleri

|Sep 09, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.

James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi

|Jul 29, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer.

Panagiotis Agisilaos Angelopoulos, Antonio Passaro, Ilaria Attili

|Jun 27, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the Top.

Pamela Trillo Aliaga, Gianluca Spitaleri, Ilaria Attili

|Jun 01, 2025
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab.

Zofia Piotrowska, Antonio Passaro, Danny Nguyen

Pageof 7

Frequent Collaborators

15 joint publications

Ilaria Attili

10 joint publications

Gianluca Spitaleri

10 joint publications

Pamela Trillo Aliaga

4 joint publications

Ambra Carnevale Schianca